IU Physician is First in Nation to Use New Dialysis Device
InsideIndianaBusiness.com Report
4/19/2006 10:38:11 AM
Dr. Michael Kraus, a physician with the Indiana University Hospital, has become the first in the nation to treat a dialysis patient with PureFlow SL, a new device created by NxStage Medical, Inc.
The device allows patients suffering from total and irreversible loss of kidney function to be treated by hemodialysis at home, instead of in a clinic or hospital.
Source: Inside INdiana Business
Press Release
INDIANAPOLIS, IN- Michael Kraus, MD, medical director of the Continuous Ambulatory Peritoneal Dialysis and Acute Dialysis Units at Indiana University Hospital and the Indiana University School of Medicine, is the first in the nation to treat a dialysis patient with PureFlow SL, a new device created by NxStage Medical, Inc., that was cleared for clinical use last week by the Food and Drug Administration (FDA). The NxStage PureFlow SL device prepares high purity dialysate (a fluid that meets and exceeds dialysis industry standards for purity) from ordinary tap water in the dialysis patient’s home.
End-stage renal disease, which causes persons to experience a total and irreversible loss of kidney function, is most commonly treated by hemodialysis, a process that artificially separates toxins and excess water from the patient’s blood. Hemodialysis usually takes place in clinics or hospitals, though some units, such as the NxStage System One device, have been adapted for home use.
The NxStage PureFlow SL is an accessory to the NxStage System One device and is designed to prepare ultra pure water from ordinary tap water and mix this water with concentrate to produce high purity dialysate. With the push of a button, the PureFlow SL automatically produces a batch of dialysate fluid ready to use with the System One to perform home hemodialysis.
“The NxStage PureFlow SL is designed to give patients and their families an easier and more convenient way to manage their home hemodialysis therapy by eliminating the need for bagged fluids,” says Dr. Kraus. “This technology offers patients an easier way to make dialysate than standard therapies. The small, minimally intrusive device improves the economics of the delivery of dialysis in order to benefit a wider variety of patients. It’s as easy as turning on the faucet and pushing a button.”
The product is small in size (about the size of an end table) and is uniquely configured to overcome the ease of use, infrastructure, and purity limitations of more traditional water treatment systems.
“This new product will make it easier for patients to take control of their own therapy in the comfort of their own homes,” says Cathy Cox, Dialysis program coordinator at Indiana University Hospital, Clarian Health Partners. “With the new PureFlow SL, patients will no longer need to store and hang bagged fluid, and with the NxStage System One’s portability, patients can still travel using dialysate in bags.”
According to officials at NxStage, PureFlow SL is scheduled for a broad commercial release in July 2006.
For more information about the IU daily dialysis program, call (317) 274-4428. For more information on NxStage and its products, please visit the company’s website at http://www.nxstage.com.
Source: Indiana University